Marielle Sanmarco

Marielle Sanmarco

Auto-generated profile, based on publicly available information

Marielle Sanmarco

Laboratoire d'Immunologie, Hôpital de la Conception, Marseille, France

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2007 in Annals of the New York Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SDSophie Desplat-Jégo
Sophie Desplat-Jégo
NBNathalie Bardin
Nathalie Bardin
BLBruno Larida
Bruno Larida
MSMarielle Sanmarco
Marielle Sanmarco

25 May 2012 in Lupus
Verified
Journal Article
Closed access
PDF file
MSM Sanmarco
M Sanmarco
NBN Bardin
N Bardin
The diagnosis of seronegative antiphospholipid syndrome (APS) has been proposed for patients with well-defined clinical APS but persistently negative for the routinely tested antiphospholipid antibodies (aPLs): antibodies to cardiolipin (aCL) and to β2 glycoprotein I (aβ2GPI) and lupus anticoagulant (LA). Antibodies directed to phosphatidylethanolamine (aPE) have been described as the sole aPLs in some patients with clinical manifestations of APS. Here, we briefly summarize the available data on the clinical associations of aPEs and propose their investigation in patients with a clinical profile highly suggestive of seronegative APS.